Top Tweets for #imdc
Proud of #IMDC Fellow Dr Heber Reyes-Garcia @heberolimus for presenting work on over 2000 patients treated with NIVO IPI for metastatic #kidneycancer. Conditional survival works and can inform patient prognosis further. @oncoalert #ASCO26
โญ @ASCOTECAG Spotlight ๐ We are visiting @heberolimus Poster presentation 05/31 09:00 AM presenting @ASCO 1L Nivolumab/Ipilimumab for mRCC: Real-world benchmarking analysis from the IMDC at board 28. Congrats @ahs_media, @imdconline, @drdanielheng et al. ๐
#ASCO26 @NazliDizman @Chris_PouliosMD @quantumonc @rohitbanwar @noha_soror @royaryam @heberolimus @IbrahimAzarOnc @Dr_Crazy94 @dominicandoc2 @OncoAlert @montypal @SPremji7866 @IMG_Oncologists @DrChoueiri @jrgralow @FionnualaCrowle @ja_ocejo @noha_soror @royaryam @OncoAlert @OncBrothers @crisbergerot @PauloBergerot @realbowtiedoc @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @jgong15 @DrSAHaddad @GIMedOnc @iandresmeraz @SakditadMD @RamilaShilpakar @RohitBanwar @lungoncdoc @BHuffmanMD @AnaVManana @AmandaNizamMD
๐ฅ New on #OncologyBytes from #IUCS2025
Dr Sara Rebuzzi shares results from the Meet-URO 33 study in mRCC.
Watch here: https://t.co/60Z4aUEL2p
#RenalCellCarcinoma #mRCC #MeetURO #IMDC #Oncoassist #Oncoalert #IUCS2026 @urologysummit @gbanna74
I love our team! Thanks for representing at #GU25 in San Francisco. I love this conference. So much learning and connecting. @IMDConline #AmazingFellows @UCalgaryMed @albertacancer @asco #GU25 @Nimira_A @Yipilimumab @DrTakemura @DrJeffreyGraham @AudreylieL
Superb presentation by the one and only @Chrislabaki1 ! 1L IO provides survival benefit in sarc-RCC AND rhabdoid-RCC in nccRCC!
@DrDanielHeng #IMDC
Excellent presentation from the #IMDC superstar lead fellow @RazaneHChehade #RHC assessing low vs low-intermediate substrata of IMDC risk groups!
@DrDanielHeng @SylvanBacaLab @DanaFarber
Very interesting to see how this discussion has evolved over the past decade. I remember ~5y ago when the choice was largely between #CM214 & #KN426; at that time, the argument for #IMDC appeared to be much stronger, for good reason. Good to have @DrDanielHeng at #AUC3 to offer a counterpoint. @AlbigesL @crisuarez08 @motzermd @DrRosenbergMSK @BraunMDPhD @MVossMD @TiansterZhang @MVossMD
All the renal cancer panel #AUC3 feel IMDC should not be used to select patients for 1st line ipi/nivo therapy. Guidlines (NCCN/ESMO) support this (weak recommendation) @DrBradMcKay @DrChoueiri @TiansterZhang @montypal
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma - โฆ@EurUrolFocusโฉ
โฆ#IMDCโฉ stuff from โฆ@IMDConlineโฉ folks โฆ@DrDanielHengโฉ โฆ@DrRanaMcKayโฉ โฆ@RazaneHChehadeโฉ โฆ@justinepanianโฉ https://t.co/qFFvTQ5B0o
Our new @IMDConline paper in @ESMO_Open led by @DrTakemura ! great job Kosuke and mentor @DrDanielHeng @albertacancer. cc: @DanaFarber_GU @DanaFarber @DanaFarberNews. Follow our @IMDConline website at: https://t.co/UQu7YZMmyv and get to know the #IMDC history with @DrDanielHeng
Just out @ESMO_Open Baseline lymphopenia (<1000 cells/ฮผl) was found in 195/966 (20%) pts with metastatic #kidneycancer receiving IO combo and was associated with worse oncologic outcomes. Special thanks to @DrChoueiri @DrDanielHeng and other collaborators @IMDConline
@brian_rini @Uromigos presenting an impressive biomarker effort for KN-426 - overall, pembro+axis superior to sunitinib in all biomarker subsets for ccRCC #ASCO24
Proud of @MartinZarba for presenting this #IMDC study. More follow up and patients required but it does highlight the importance of VEGF inhibition in very favorable patients. They are the most sensitive. #hypothesisgenerating #ASCO24 @OncoAlert
The IMDC story continues with a new very favourable group (good risk with no visceral mets and 3yrs since surgery).All the pts did well but Ipi/nivo was least impressive. Modest numbers & patient selection confounding, but there are VEGF mono sensitive slow growing tumors #ASCO24
Dr. Zabra #IMDC analysis of #1L favorable/very favorable risk adv #RCC
No diff in OS among regimens in all favorable risk but better ORR w/VEGF-TKI+IO but worse OS and ORR w/nivo + ipi in very favorable risk disease
#ASCO24 @oncoalert
Great presentation by Martin Zarba discussing therapeutic options in pts with favorable and very favorable risk #mRCC from the #IMDC database!
@DrDanielHeng @TalalZarif1 @eddy_saad @KarlSemaan
@ASCO @Oncoalert #ASCO24
Great presentation by @ZarbaMartin1 at #ASCO24
A subgroup analysis of #IMDC of favorable and very favorable risk patients.
Still a #VEGF inhibitors are the pillar of treatment for this subgroup.
Come see our #IMDC fellow @Martinzarba Saturday 8am Room S100bc present on the Favorable risk and VERY favorable risk metastatic #kidneycancer population for potential guidance on therapy selection. #IMDConline @DrChoueiri @montypal @tompowles1 @ravikanesvaran @OncoAlert #ASCO24
Tom Powles on new @myESMO guidelines for renal cancer
@tompowles1
https://t.co/EsO4zLyXxT
#Cancer #BartsCancerCenter #Belzutifan #ESMO #IMDC #RenalCancer #OncoDaily #Oncology
I had the pleasure of meeting with Daniel Heng, the creator of the IMDC prognostic risk criteria for aRCC - Olubukola Ayodele
https://t.co/TVi8DrGZ4Q
#oncodaily #oncology #cancer #IMDC #prognosticcriteria #biomarkers #treatmentdecision #pathology #precisionmedicine
Last Seen Hashtags on Sotwe
ๆผๅบV
Seen from Korea
็ฒพๆถฒๅๆ
Seen from Malaysia
thots video
Seen from United States
teen videos going
Seen from Turkey
bowuiginsfw
Seen from Panama
gachavore
Seen from United Kingdom
เนเธขเนเธเนเธเธทเนเธญเธ
Seen from Thailand
ๅธๅฅถ
Seen from United States
nolimit() +filter:native_video()
Seen from Turkey
ๆทซๅ
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
240.5M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.6M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.5M followers
Taylor Swift
@taylorswift13
81.4M followers
Lady Gaga
@ladygaga
72.9M followers
Kim Kardashian
@kimkardashian
69.7M followers
Virat Kohli
@imvkohli
69.7M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.8M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62.4M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.6M followers